Dr. Nupur Kohli is a biomedical scientist and academic whose career spans regenerative medicine, stem cell biology, biomaterials, and translational musculoskeletal research, with a strong commitment to advancing innovative therapies and bridging laboratory discoveries with real-world clinical applications. She serves as an Assistant Professor of Biomedical Engineering at Khalifa University, where she leads a regenerative therapies laboratory focused on developing stem cell–based and bioengineered solutions for complex musculoskeletal conditions while contributing to curriculum development and departmental growth. Her earlier roles across leading institutions in the United Kingdom, Japan, and the United Arab Emirates include pioneering sterile tissue culture facilities, developing bioreactor systems for implant evaluation, establishing angiogenesis testing laboratories, and inventing a patented extracellular matrix biomaterial currently progressing through pre-clinical testing. Her scholarship encompasses high-impact publications in internationally reputed journals, book chapters, invited talks, and peer-review contributions, reflecting a sustained record of scientific leadership and innovation. She has cultivated collaborations with globally recognized institutions, including Imperial College London, Karolinska Institute, and multidisciplinary teams of clinicians and engineers, enabling cross-sectoral research with strong translational relevance. Her work has also contributed to identifying molecular biomarkers, optimizing scaffold-based regeneration strategies, and advancing multi-omics–driven approaches to autoimmune and inflammatory disorders. Beyond academia, she actively supports capacity building through mentoring, developing internship programs, strengthening student engagement initiatives, and fostering entrepreneurial activities, including founding a biotechnology start-up focused on regenerative technologies. Her contributions have been recognized through competitive awards, invited presentations, professional memberships, and affiliations with international societies dedicated to stem cell science and biomedical engineering. Dr. Kohli’s research and innovation efforts continue to influence regenerative medicine, personalized therapies, and biomaterial development, demonstrating a profound societal impact through advancing scientific knowledge, improving clinical pathways, and supporting the future workforce in health and biomedical sciences. She has 614 citations from 25 documents with an h-index of 13.
Profiles: Google Scholar | Scopus
Publications
1. Kohli, N., Ho, S., Brown, S. J., Sawadkar, P., Sharma, V., Snow, M., & colleagues. (2018). Bone remodelling in vitro: Where are we headed? A review on the current understanding of physiological bone remodelling and inflammation and the strategies for testing.
2. Kohli, N., Stoddart, J. C., & van Arkel, R. J. (2021). The limit of tolerable micromotion for implant osseointegration: A systematic review.
3. Kohli, N., Wright, K. T., Sammons, R. L., Jeys, L., Snow, M., & Johnson, W. E. B. (2015). An in vitro comparison of the incorporation, growth, and chondrogenic potential of human bone marrow versus adipose tissue mesenchymal stem cells in scaffolds.
4. Sawadkar, P., Mohanakrishnan, J., Rajasekar, P., Rahmani, B., Kohli, N., & colleagues. (2020). A synergistic relationship between polycaprolactone and natural polymers enhances the physical properties and biological activity of scaffolds.
5. Kohli, N., Sharma, V., Orera, A., Sawadkar, P., Owji, N., Frost, O. G., Bailey, R. J., & colleagues. (2021). Pro-angiogenic and osteogenic composite scaffolds of fibrin, alginate and calcium phosphate for bone tissue engineering.